As of 2024-10-10, the EV/EBITDA ratio of Insmed Inc (INSM) is -19.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSM's latest enterprise value is 11,975.47 mil USD. INSM's TTM EBITDA according to its financial statements is -620.57 mil USD. Dividing these 2 quantities gives us the above INSM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 16.9x | 14.9x |
| Forward P/E multiples | 16.6x - 19.1x | 17.5x |
| Fair Price | (59.60) - (60.75) | (58.23) |
| Upside | -185.2% - -186.8% | -183.2% |
| Date | EV/EBITDA |
| 2024-10-10 | -19.68 |
| 2024-10-09 | -19.30 |
| 2024-10-08 | -19.69 |
| 2024-10-07 | -19.45 |
| 2024-10-04 | -19.94 |
| 2024-10-03 | -19.70 |
| 2024-10-02 | -20.14 |
| 2024-10-01 | -20.11 |
| 2024-09-30 | -20.14 |
| 2024-09-27 | -20.00 |
| 2024-09-26 | -20.10 |
| 2024-09-25 | -20.07 |
| 2024-09-24 | -20.04 |
| 2024-09-23 | -19.81 |
| 2024-09-20 | -20.47 |
| 2024-09-19 | -20.68 |
| 2024-09-18 | -20.10 |
| 2024-09-17 | -20.21 |
| 2024-09-16 | -20.20 |
| 2024-09-13 | -20.60 |
| 2024-09-12 | -20.39 |
| 2024-09-11 | -20.07 |
| 2024-09-10 | -19.74 |
| 2024-09-09 | -19.81 |
| 2024-09-06 | -19.60 |
| 2024-09-05 | -20.11 |
| 2024-09-04 | -20.76 |
| 2024-09-03 | -20.22 |
| 2024-08-30 | -21.10 |
| 2024-08-29 | -21.06 |
| 2024-08-28 | -21.12 |
| 2024-08-27 | -21.28 |
| 2024-08-26 | -20.75 |
| 2024-08-23 | -21.76 |
| 2024-08-22 | -21.80 |
| 2024-08-21 | -21.25 |
| 2024-08-20 | -21.02 |
| 2024-08-19 | -21.41 |
| 2024-08-16 | -21.03 |
| 2024-08-15 | -20.46 |
| 2024-08-14 | -20.66 |
| 2024-08-13 | -21.08 |
| 2024-08-12 | -20.44 |
| 2024-08-09 | -20.41 |
| 2024-08-08 | -19.81 |
| 2024-08-07 | -19.58 |
| 2024-08-06 | -20.05 |
| 2024-08-05 | -19.64 |
| 2024-08-02 | -19.81 |
| 2024-08-01 | -20.78 |